Published in Diabet Med on July 01, 2005
Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus. PLoS Med (2007) 1.34
Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patients with type 1 diabetes. Diabetes Care (2012) 1.01
Self-reported discrimination, diabetes distress, and continuous blood glucose in women with type 2 diabetes. J Immigr Minor Health (2015) 0.86
Hypoglycemia impairs quality of blood glucose simulation in a clinical decision support system. J Diabetes Sci Technol (2011) 0.83
Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups. Indian J Endocrinol Metab (2014) 0.80
Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma. Diabetol Metab Syndr (2017) 0.75
Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med (1991) 1.93
Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med (2006) 1.86
Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr (1992) 1.52
Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ (1995) 1.50
Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr (1994) 1.50
Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin. Br Med J (Clin Res Ed) (1985) 1.47
The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia (2005) 1.44
Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr (1994) 1.34
The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients. J Intern Med (1990) 1.15
Cognitive function during hypoglycaemia in type I diabetes mellitus. Br Med J (Clin Res Ed) (1986) 1.15
Self-reported non-severe hypoglycaemic events in Europe. Diabet Med (2013) 1.14
Glycaemic threshold for changes in electroencephalograms during hypoglycaemia in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) (1988) 1.14
A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. J Diabetes Complications (2001) 1.10
Modeling absorption kinetics of subcutaneous injected soluble insulin. J Pharmacokinet Biopharm (1989) 1.09
Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract (2009) 1.04
Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med (2012) 1.04
Primary gastrointestinal non-Hodgkin's lymphoma in adults: a population-based clinical and histopathologic study. J Intern Med (1998) 1.02
Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) (1993) 1.02
Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract (2011) 1.01
Renal threshold for glucose in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract (1997) 1.00
Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet (2001) 0.99
Glucose tolerance in cystic fibrosis. Arch Dis Child (1991) 0.98
Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med (1999) 0.95
Impaired glucose tolerance and diabetes mellitus in elderly subjects. Diabetes Care (1987) 0.94
Haemodynamic effects of eating: the role of meal composition. Clin Sci (Lond) (1996) 0.91
Lower levels of circulating IGF-I in Type 1 diabetic women with frequent severe hypoglycaemia during pregnancy. Diabet Med (2008) 0.89
Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia (2002) 0.89
Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients: relation to daily median blood glucose concentrations. Diabet Med (1986) 0.88
Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside. BMJ (1991) 0.88
Pain, tenderness, wheal and flare induced by substance-P, bradykinin and 5-hydroxytryptamine in humans. Cephalalgia (1991) 0.87
Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr (1993) 0.85
Effects of insulin on renal haemodynamics and sodium handling in normal subjects. Scand J Clin Lab Invest (1991) 0.85
Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects. Acta Endocrinol (Copenh) (1984) 0.84
NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system activity. J Appl Physiol (1985) (2008) 0.84
A reevaluation of atrial fibrillation in thyrotoxicosis. Dan Med Bull (1984) 0.83
Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial. Diabetes Obes Metab (2009) 0.83
Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis. Clin Genet (1991) 0.83
Pain and tenderness in human temporal muscle induced by bradykinin and 5-hydroxytryptamine. Peptides (1991) 0.82
Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf) (1994) 0.82
Pain, wheal and flare in human forearm skin induced by bradykinin and 5-hydroxytryptamine. Peptides (1991) 0.81
Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. Diabet Med (2012) 0.80
Varenicline may trigger severe hypoglycaemia in Type 1 diabetes. Diabet Med (2008) 0.80
Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated Type 2 diabetes. Diabet Med (2009) 0.79
A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes. Diabetologia (2011) 0.78
Long-term insulin-dependent diabetes mellitus with secondary pituitary insufficiency and regression of retinopathy. Acta Med Scand (1983) 0.78
[A prospective study of back complaints in recruits]. Ugeskr Laeger (1982) 0.78
Iodine-induced hyperthyroidism and bronchial asthma. Lancet (1977) 0.77
The relationship between plasma concentration and plasma disappearance rate of immunoreactive insulin in normal subjects. Diabetologia (1982) 0.77
Severe hypoglycaemia during pregnancy in women with type 1 diabetes: possible role of renin-angiotensin system activity? Diabetes Res Clin Pract (2009) 0.77
Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects. Acta Endocrinol (Copenh) (1988) 0.77
Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus. Diabetologia (2005) 0.77
[Pituitary function in hemochromatosis]. Ugeskr Laeger (1996) 0.77
Non-linearity of insulin kinetics. Diabetologia (1986) 0.76
The content of water and potassium in fat cells. Biochim Biophys Acta (1976) 0.75
Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes. Eur J Endocrinol (2010) 0.75
Correlation between the routine 6-min. C-peptide value and the AUC after I.V. glucagon injection in NIDDM patients. Horm Metab Res (1982) 0.75
[Glucose tolerance in patients with cystic fibrosis]. Ugeskr Laeger (1996) 0.75
[Pneumococcal vaccination and diabetes]. Ugeskr Laeger (1997) 0.75
[Plasma concentrations of C-peptide and glucose during glucose tolerance tests. The effects of running]. Ugeskr Laeger (1985) 0.75
Kinetics of insulin disappearance from plasma in cortisone-treated normal subjects. Clin Endocrinol (Oxf) (1987) 0.75
Pharmacokinetics of intermediate-acting insulins: tracer studies. Neth J Med (1985) 0.75
Kinetic models for insulin disappearance from plasma in type I diabetic patients. Pharmacol Toxicol (1987) 0.75
[Iodine-induced thyrotoxicosis]. Ugeskr Laeger (1979) 0.75
The C-peptide response to glucagon injections in IDDM and NIDDM patients. Horm Metab Res (1985) 0.75
Subcutaneous absorption of U-40 and U-100 insulin. Horm Metab Res (1984) 0.75
ACTH stimulation test in patients with type 1 diabetes and recurrent severe hypoglycaemia. Clin Endocrinol (Oxf) (2014) 0.75
[Insulin shock treated at casualty departments. A retrospective analysis of 120 episodes]. Ugeskr Laeger (1986) 0.75
[Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets]. Ugeskr Laeger (1980) 0.75
[Back complaints among Danish recruits]. Ugeskr Laeger (1982) 0.75
The incidence of severe hypoglycaemia in pregnant women with type 1 diabetes mellitus can be reduced with unchanged HbA1c levels and pregnancy outcomes in a routine care setting. Diabetes Res Clin Pract (2013) 0.75
Kinetic models for plasma disappearance of insulin in normal subjects. Acta Pharmacol Toxicol (Copenh) (1985) 0.75
Diabetes care: a guideline to the facilities needed to support internationally endorsed standards. Diabet Med (1995) 0.75